Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) Research & Development (2016 - 2025)

Historic Research & Development for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to $1.5 million.

  • Myomo's Research & Development rose 2232.34% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 6817.08%. This contributed to the annual value of $4.8 million for FY2024, which is 8099.89% up from last year.
  • According to the latest figures from Q3 2025, Myomo's Research & Development is $1.5 million, which was up 2232.34% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Myomo's Research & Development ranged from a high of $2.0 million in Q2 2025 and a low of $476991.0 during Q1 2023
  • In the last 5 years, Myomo's Research & Development had a median value of $717256.0 in 2023 and averaged $934997.1.
  • In the last 5 years, Myomo's Research & Development plummeted by 3655.96% in 2022 and then soared by 10046.81% in 2024.
  • Quarter analysis of 5 years shows Myomo's Research & Development stood at $787628.0 in 2021, then tumbled by 36.56% to $499674.0 in 2022, then soared by 75.72% to $878007.0 in 2023, then soared by 77.64% to $1.6 million in 2024, then fell by 2.05% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $2.0 million for Q2 2025, and $1.8 million during Q1 2025.